The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated in the United StatesTherapy granted United States Food ...

First-of-its-kind venture to facilitate and catalyze development of deprioritized cell and gene therapies, supported by AI-enabled platform MILWAUKEE and CAMBRIDGE, Mass.

Walz was echoing a question that U.S. Army lawyer Joseph Welch posed to Republican U.S. Sen. Joseph McCarthy of Wisconsin ...

After over six years as a thrift-style store, One Less Orphan Bookstore had its soft opening Tuesday at 1456 Olney Ave. SE, ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today ...

LYNX-3, the second pivotal Phase 3 trial in keratorefractive participants with visual disturbances under mesopic, low-contrast conditions, is ongoing with topline results expected in the first half of ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Having already jumped on the romantasy train that dominated bestseller lists in 2025, including A Forbidden Alchemy by Stacey ...

Enrollment of pivotal cohort expected to begin in Q1 2026; ATSN-201 BLA submission on track for early 2028DURHAM, N.C., Jan. 08, 2026 (GLOBE ...

On Wednesday, the former Kansas City resident became known worldwide as the woman shot and killed by an Immigration and Customs Enforcement agent in Minneapolis.

Equity-Insider.com News Commentary ? Biopharma M&A is entering a fever pitch, with precision oncology investments alone exploding to $138 billion as major players scramble to secure proven cancer ...